$11.21 UiPath (PATH) NYSE pre-market 24 Feb 2026: analysts eye $15.77 target
PATH stock trades at $11.21 pre-market on 24 Feb 2026, up 3.80% as investors weigh automation demand ahead of UiPath’s earnings. UiPath Inc. (PATH) on the NYSE is navigating soft YTD performance while showing strong cash reserves and profit margins. We examine valuation, technicals, analyst targets, and short-term catalysts including the next earnings date on 2026-03-11. This note uses Meyka AI data and market signals to frame risks and near-term opportunities for U.S. investors in the Technology sector.
PATH stock price and technicals
UiPath (PATH) opened pre-market at $11.12 and trades at $11.21 with a daily high of $11.24 and low of $10.93. Technical indicators show RSI 26.90, a sign of oversold conditions, and ADX 35.61, which implies a strong directional trend. Volume of 21,534,416 shares is below the 50-day average but above the 200-day average on recent moves. The 50-day moving average sits near $14.84 and the 200-day at $13.54, highlighting the recent downtrend versus longer-term support.
PATH stock fundamentals and valuation
UiPath reports EPS 0.42 and a trailing PE of 24.21, with market cap near $5,437,686,976.00 on the NYSE in the United States. Price-to-sales is 3.49 and price-to-book is 2.84, reflecting premium software multiples despite recent share weakness. The company shows strong margins with gross profit margin 0.83 and free cash flow yield 0.06. CurrentRatio is 2.54, indicating liquidity buffers that reduce near-term solvency risk.
PATH stock catalysts and risks
Catalysts include accelerating AI adoption in enterprise automation and a March earnings report on 2026-03-11 that could reset consensus revenue and guidance. Wall Street targets range from $14.00 to $19.00, with a MarketBeat consensus near $15.77. Risks include high receivables (days sales outstanding 116.59), slowing revenue growth versus peak trends, and insider sales disclosed in recent filings. Short interest and mixed broker ratings suggest event-driven volatility in the near term.
Meyka AI rates PATH with a score out of 100
Meyka AI rates PATH with a score of 76.35 out of 100 and assigns a B+ (BUY) suggestion. This grade factors in S&P 500 comparison, sector and industry performance, financial growth, key metrics, and analyst consensus. The grade balances solid cash metrics and margin recovery against YTD weakness and multiple compression. These grades are informational only and not financial advice.
Meyka AI’s forecast model projects PATH stock
Meyka AI’s forecast model projects a yearly price of $16.48, a quarterly target of $15.64, and a monthly level near $9.02. Versus the current $11.21 price, the one-year forecast implies an upside near 47.06%. Forecasts are model-based projections and not guarantees. We pair model outputs with analyst targets and institutional flows to set realistic scenarios for trading and longer-term investment in UiPath.
PATH stock outlook and analyst targets
Analysts remain mixed with most rated Hold and a consensus price target about $15.77. Recent broker moves include Morgan Stanley raising its target to $19.00 and DA Davidson to $15.00. Institutional buying by funds like Hillsdale has increased position sizes, while insider transactions add noise. For U.S. investors focused on AI stocks, PATH sits as a mid-cap automation play with exposure to enterprise AI budgets and software spending cycles.
Final Thoughts
Key takeaways: PATH stock trades at $11.21 pre-market on 24 Feb 2026 with technicals signalling oversold conditions and a mixed fundamental picture. Meyka AI’s forecast model projects a yearly price of $16.48, implying about 47.06% upside versus the current price. That forecast sits above the MarketBeat consensus of $15.77, and below the most bullish analyst target of $19.00. Balance the stock’s PE of 24.21, healthy cash per share $2.59, and current ratio 2.54 against receivables and YTD weakness. For AI-focused portfolios, PATH offers leveraged exposure to enterprise automation, but expect volatility through the March earnings event. Forecasts are model-based projections and not guarantees. We use Meyka AI as an AI-powered market analysis platform to frame these scenarios and recommend monitoring earnings and guidance for directional confirmation.
FAQs
What drove PATH stock recent moves?
PATH stock moved on a mix of analyst reprice and institutional buying. Technical oversold signals and an upcoming earnings date on 2026-03-11 heightened trading volume and volatility.
What is Meyka AI’s price forecast for PATH stock?
Meyka AI’s forecast model projects a yearly price of $16.48 for PATH stock, implying roughly 47.06% upside versus the current $11.21. Forecasts are projections, not guarantees.
How do analysts view PATH stock valuation?
Most analysts rate UiPath as Hold with a consensus target near $15.77. Broker targets range $14.00 to $19.00, reflecting mixed views on growth and margin sustainability.
Should investors watch PATH stock before earnings?
Yes. PATH stock may react strongly to guidance on 2026-03-11. Monitor revenue and subscription growth, margin commentary, and receivables trends for short-term direction.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.